COVID-19 relief funding, oversight, and the strings attached
By
Marleah Keuler-Grahek
Jul 29, 2021
Over the past year, long-term care providers have received unprecedented amounts of federal funding as a result of the COVID-19 pandemic. Not only do providers want to avoid recoupment of these funds,...
Penalties surge under new law
By
John O'Connor
Dec 04, 2015
The new federal budget could prove costly for accused providers.
Court revives PharMerica whistleblower case
By
Dec 21, 2015
A previously dismissed whistleblower case against long-term care pharmacy titan PharMerica Corp. is getting a second wind thanks to a ruling last week by the U.S. Court of Appeals.
X-ray exec who targeted nursing homes is sentenced in $3.7 million fraud case
By
Joe Bush
Oct 03, 2022
A man who charged Medicare and Medicaid for X-rays he had not taken of people who had died has been sentenced to 15 years in jail and ordered to pay almost $2 million in restitution.
Prison sentence in Medicare fraud conviction is excessive, court rules
By
Jun 23, 2015
A federal appeals court has found that a 68-month prison term for a provider convicted of Medicare fraud is too excessive.
Johnson & Johnson to pay $2 billion in settlement over antipsychotic drugs in nursing homes
By
Tim Mullaney
Nov 05, 2013
Pharmaceuticals giant Johnson & Johnson and some subsidiaries will pay more than $2.2 billion to settle claims that they inappropriately promoted antipsychotic drugs for use in nursing homes, the U.S....
Final revisions to fraud rules expected by spring
By
Nov 30, 2015
Revisions to three healthcare fraud and abuse rules, including one that would increase the Office of Inspector General’s ability to impose civil monetary penalties, are expected to be finalized by...
Providers increasingly on the hook for employees’ drug thefts
By
Kimberly Marselas
Mar 04, 2024
Violations of the Controlled Substance Act — including staff who divert patient medications for themselves — may open providers up to additional False Claims Act liability, warn a group of attorneys...
Pharma company to pay $95 million in settlement for ‘off-label’ drug promotion
By
McKnight's Staff
Oct 30, 2012
A pharmaceutical company will pay $95 million over allegations of kickbacks regarding three medications used in skilled nursing facilities and hospitals.
Kindred pharmacy affiliate to pay $1.3 million in drug over-billing lawsuit
Jun 18, 2009
Kindred Healthcare Inc.’s affiliate PharMerica Corp. will pay $1.3 million in a settlement with the federal government and the state of Tennessee. It allegedly over-charged the state’s Medicaid...